No relevant relationships with ineligible companies to disclose within the past 24 months.
The Heart Failure Society of America estimates more than 6.5 million Americans over the age of 20 have heart failure with nearly a million new cases of heart failure diagnosed annually. Primary care providers are integral to the treatment of heart failure patients. Guideline-directed medical therapies in 2024 are complex and require a strong understanding of implementing therapies and mitigating barriers to care. This session will review current medical treatments and strategies for success.
Learning Objectives:
At the conclusion of this session, participants should be able to:
Recall guideline-directed medical therapy for the treatment of heart failure according to the ACC guidelines
Discuss strategies for initiation and titration of guideline-directed medical therapy
Describe laboratory and radiologic studies used to assess response to therapy and disease progression
Identify barriers to care and mitigation strategies for heart failure patients
